| Mitotic clustering of pulverized chromosomes from micronuclei YF Lin, Q Hu, A Mazzagatti, JE Valle-Inclán, EG Maurais, R Dahiya, ... Nature 618 (7967), 1041-1048, 2023 | 42 | 2023 |
| VRK1 is a synthetic–lethal target in VRK2-deficient glioblastoma JA Shields, SR Meier, M Bandi, EE Mulkearns-Hubert, N Hajdari, ... Cancer Research 82 (21), 4044-4057, 2022 | 27 | 2022 |
| Ubiquitinated PCNA drives USP1 synthetic lethality in cancer A Simoneau, JL Engel, M Bandi, K Lazarides, S Liu, SR Meier, AH Choi, ... Molecular Cancer Therapeutics 22 (2), 215-226, 2023 | 25 | 2023 |
| Boveri and beyond: Chromothripsis and genomic instability from mitotic errors A Mazzagatti, JL Engel, P Ly Molecular cell, 2024 | 23 | 2024 |
| DCAF14 promotes stalled fork stability to maintain genome integrity A Townsend, G Lora, J Engel, N Tirado-Class, H Dungrawala Cell reports 34 (4), 2021 | 15 | 2021 |
| Non-homologous end joining shapes the genomic rearrangement landscape of chromothripsis from mitotic errors Q Hu, J Espejo Valle-Inclán, R Dahiya, A Guyer, A Mazzagatti, ... Nature communications 15 (1), 5611, 2024 | 5 | 2024 |
| The Fanconi anemia pathway induces chromothripsis and ecDNA-driven cancer drug resistance JL Engel, X Zhang, M Wu, Y Wang, JE Valle-Inclán, Q Hu, ... Cell 187 (21), 6055-6070. e22, 2024 | 3 | 2024 |
| VRK1 is a paralog synthetic lethal target in VRK2-methylated glioblastoma JA Shields, SR Meier, M Bandi, MD Ferdinez, JL Engel, ... Biorxiv, 2021.12. 30.474571, 2022 | 2 | 2022 |
| UMIBB: A novel nonparametric Bayesian method improves robustness and sensitivity of analysis in pooled CRISPR-Cas9 screens leveraging unique molecular identifiers A Choi, S Meier, S Fenoglio, T Feng, J Engel, B Shen, S Liu, T Teng, ... Cancer Research 82 (12_Supplement), 1224-1224, 2022 | | 2022 |
| USP1 inhibitor synthetic lethality in BRCA1-mutant cancer is driven by PCNA ubiquitination J Engel, M Bandi, A Simoneau, K Lazarides, D Gotur, T Pham, S Liu, ... Cancer Research 82 (12_Supplement), 2603-2603, 2022 | | 2022 |
| Abstract P182: VRK1 is a novel synthetic lethal target in VRK2-methylated glioblastoma J Shields, SR Meier, J Engel, M Bandi, ML Dam Ferdinez, W Zhang, ... Molecular Cancer Therapeutics 20 (12_Supplement), P182-P182, 2021 | | 2021 |
